FC
PTCT icon

FORA Capital’s PTC Therapeutics PTCT Stock Holding History

FORA Capital’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,925
Closed -$1.06M – 571
2025
Q4 		$1.06M Buy
13,925
+8,098
+139% +$589K 0.13% 197
2025
Q3 		$358K Buy
+5,827
New +$304K 0.06% 345
2021
Q1 		– Sell
-820
Closed -$50K – 1033
2020
Q4 		$50K Sell
820
-443
-35% -$26.1K 0.01% 772
2020
Q3 		$59K Buy
1,263
+749
+146% +$36.9K 0.04% 413
2020
Q2 		$26K Buy
+514
New +$25.3K 0.01% 768
2020
Q1 		– Sell
-5,528
Closed -$266K – 1272
2019
Q4 		$266K Buy
+5,528
New +$235K 0.03% 548

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FORA Capital's PTCT Position: Q1 2026 in Review

FORA Capital sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 13,925 shares — an estimated $1.06M sold.

FORA Capital first reported a position in PTCT in Q4 2019 and held it in 6 quarters. The position peaked at $1.06M in Q4 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • FORA Capital reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • FORA Capital sold 13,925 PTC Therapeutics shares in Q1 2026, an estimated $1.06M.
  • FORA Capital first reported a position in PTC Therapeutics in Q4 2019 and held it in 6 quarters.
  • FORA Capital's PTC Therapeutics position peaked at $1.06M in Q4 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.